Strengths

● The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.

● The company returns high margins, thereby supporting business profitability.

● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.

● Given the positive cash flows generated by its business, the company's valuation level is an asset.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.

● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.

● For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.


Weaknesses

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● The overall consensus opinion of analysts has deteriorated sharply over the past four months.

● Over the past twelve months, analysts' consensus has been significantly revised downwards.

● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.